Contact this trialFirst, we need to learn more about you.
Chemotherapy
Docetaxel for Non-Small Cell Lung Cancer
Recruiting3 awardsPhase 3
Westwood, Kansas
This trial is comparing the overall survival of patients with NSCLC who receive second- or third-line systemic therapy with docetaxel + plinabulin to those who receive docetaxel + placebo.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service